Articles Posted in Mass Torts

A spinal cord stimulator is an implantable medical device used to manage chronic pain, most often involving the back or spine. These systems are marketed as a way to reduce pain by interrupting nerve signals before they reach the brain. But for a growing number of patients, the device fails to help. It introduces new and sometimes permanent problems, including electrical shocks, burning pain, infections, lead migration, hardware failure, and repeat surgeries to reposition or remove equipment that was supposed to improve quality of life.

This page explains spinal cord stimulator lawsuits and why they are being filed nationwide. It focuses on what patients are alleging, how these devices have failed in real-world use, and why many of these cases go beyond ordinary medical malpractice claims. The most serious lawsuits do not center on a single surgical mistake. They examine how modern spinal cord stimulators were designed, tested, and approved, and whether patients were ever adequately warned about the risks that now recur repeatedly in medical records and FDA reports.

Many victims want to know what spinal cord stimulator settlement amounts will look like and how we think compensation will be calculated, assuming an ultimate settlement. Settlement amounts and payouts in these cases will depend on several factors, which we dig into more fully below.

Bard PowerPort lawsuits allege that defects in implanted port catheters can cause fractures, migration, blood clots, infections, embolisms, and other serious complications. Thousands of product liability lawsuits are now pending against Bard and its parent company, Becton Dickinson, in a federal multidistrict litigation in Arizona. After a long slog, these cases are now moving forward.

The first bellwether trial ended with a partial defense verdict and a deadlocked jury on the central design defect claim. The most recent completed trial, Divelbliss v. C.R. Bard, led to a $40 million verdict. It involved an alleged fracture of a silicone Groshong catheter. Five bellwether trials are now expected to run through February 2027. The first two trials produced very different results, and the third trial began in October 2026. Our lawyers remain bullish on well-documented fracture, migration, and embolization cases.

This page provides the latest Bard PowerPort lawsuit updates, projected settlement amounts, and information about who may qualify to file a claim.

This page provides updates on Camp Lejeune lawsuits.

Our lawyers are still working to give the latest update on the litigation, even though we are no longer taking new cases. Why? Because there is little information out there, and we are staying with victims, including those we do not represent, until the end.

We recently reopened the comments below on October 19 to give you a chance to share your thoughts.

This page is about social media addiction lawsuits and who is eligible to bring a claim. Our lawyers also provide the latest news on social media lawsuits, including the upcoming trial in California and the federal social media addiction MDL.

The problem that led to social media lawsuits is that millions of people, too many of whom are children, are addicted to social media platforms such as Facebook, Instagram, Snapchat, TikTok, and YouTube. For these vulnerable users, social media addiction can be very harmful and lead to things like eating disorders, depression, self-harm, and, in some cases, suicide.

Now, these companies are facing a wave of lawsuits alleging that they knowingly designed the algorithms of their platforms to lure young people into harmful addictions.

The Apple AirTag litigation now includes a federal MDL for people who allege that Apple AirTags were used to stalk, track, threaten, or harm them. On October 2, 2026, the Judicial Panel on Multidistrict Litigation consolidated the federal AirTag stalking lawsuits into MDL No. 3199 in the Northern District of California, transferring 17 lawsuits from 13 federal districts to one judge.

There is no AirTag settlement for all victims. Not yet. But Apple says it has already settled a number of individual AirTag stalking claims. The Apple AirTag MDL gives us a chance to screen these cases and put them on an organized path forward. It is rare to be talking settlement this early in an MDL. But Apple has already shown that it is willing to resolve at least some of these claims.

What are these cases about? The core allegation is simple. Apple created a small, inexpensive, remarkably effective tracking device that could be hidden in a car, purse, backpack, or other personal property. For most uses, it is a fantastic device. The problem is Apple knew before AirTag was released that the device could be abused for stalking. Of course, Apple did not want this and built anti-stalking protections. The claim in these lawsuits is that those protections were not nearly enough to protect some victims.

Our lawyers are reviewing hair relaxer cancer lawsuits for women across the United States. These claims involve women who used chemical hair relaxers or hair straighteners for years and were later diagnosed with uterine cancer, including endometrial cancer, ovarian cancer, or serious uterine fibroids that led to a hysterectomy.

The federal hair relaxer litigation included 12,381 pending lawsuits as of October 1, 2026. The cases are moving through expert discovery and bellwether preparation in the Northern District of Illinois. This litigation has been going on for years, but there is still no global hair relaxer settlement or MDL payout program.  That does not mean our lawyers are not bullish on these cases. We are. It is just moving slowly, which is how it goes sometimes in the MDL mass torts. We still expect a favorable global settlement when all is said and done.

The strongest cases generally involve frequent, long-term use followed by uterine or ovarian cancer, a clear product history, and substantial treatment or reproductive injury.

Our lawyers are now focusing our attention on the Medtronic Bravo CF capsule recall.

This device is used to diagnose acid reflux and gastroesophageal reflux disease (GERD). In September 2026, the FDA classified a major recall of these devices as Class I, the agency’s most serious recall category.

This should be a simple no-frills test. A doctor attaches a small capsule to the lining of the patient’s esophagus. The capsule measures acidity and transmits readings to a receiver the patient wears. The goal is to determine whether the patient has acid reflux.

Thousands of hernia mesh lawsuits are pending in courts across the country. Our hernia mesh lawyers are handling these cases in all 50 states.

The plaintiffs in these lawsuits are individuals with defective hernia mesh implanted during surgery, causing them to suffer severe post-surgical complications and injuries.

The hernia mesh lawsuits involve multiple hernia mesh products made by four medical device companies that are in (or were in) the litigation: Ethicon (a Johnson & Johnson subsidiary that has reached a settlement in most of its lawsuits), C.R. Bard (now part of Becton Dickinson), Covidien, and Atrium Medical Corp.

This page explains the Suboxone tooth decay lawsuits, the dental injuries linked to Suboxone film, and where the federal MDL stands in 2026.

The core claim in the Suboxone litigation is straightforward: plaintiffs allege that Indivior and related defendants knew, or should have known, that Suboxone film could cause severe dental damage, including tooth decay, enamel erosion, broken teeth, tooth loss, and expensive dental reconstruction. Plaintiffs contend the companies failed to warn patients and prescribing doctors until the FDA required a dental warning in 2022.

Our lawyers are still taking selected Suboxone tooth decay lawsuits in 2026. We are screening these cases more carefully than we did earlier in the litigation. We know more now and, from seeing literally thousands of cases, we have a tighter handle on what we think will generate a Suboxone settlement.

Contact Information